Business and Commerce
Press release
Sahajanand Medical Technologies Secures Regulatory Approval in Egypt for Supraflex Cruz Coronary Stent
Sahajanand Medical Technologies (SMT) has received regulatory approval from the Egyptian Drug Authority (EDA), Central Administration of Medical Devices, for its Supraflex Cruz Sirolimus Eluting Stent System, marking the company’s entry into a new market in Africa. This EDA approval gives physicians in Egypt access to the Supraflex Cruz...